Macro Group Pharmaceuticals (Macro Capital) S.A.E (EGX:MCRO)
Egypt flag Egypt · Delayed Price · Currency is EGP
1.590
+0.020 (1.27%)
At close: Oct 4, 2026

EGX:MCRO Cash Flow Statement

Millions EGP. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
126.65115.73-38.1-272.65173.84147.93
Depreciation & Amortization
19.0617.1316.5616.7213.626.6
Other Amortization
0.380.380.380.510.68-
Loss (Gain) From Sale of Assets
--0.330.02--
Asset Writedown & Restructuring Costs
---24.42--
Loss (Gain) From Sale of Investments
-3.52--3.29---
Provision & Write-off of Bad Debts
29.5829.5835.6898.433.150.5
Other Operating Activities
70.3431.3737.0347.8720.520.47
Change in Accounts Receivable
-66.42-1.33-168.85104.94-33.58-131.35
Change in Inventory
-53.3-20.1520.44-67.65-73.12-19.33
Change in Accounts Payable
36.8144.68-18.5720.2527.7416.69
Change in Other Net Operating Assets
-76.69-56.443.94-10.872.18.74
Operating Cash Flow
82.88160.99-74.45-38.01134.9350.26
Operating Cash Flow Growth
----168.47%9.39%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-34.85-42.48-12.32-6.44-5.3-5.81
Sale of Property, Plant & Equipment
0.620.62-0.04--
Cash Acquisitions
------1.5
Sale (Purchase) of Intangibles
0.43----3.5-
Investment in Securities
--3.29---
Other Investing Activities
7.879.395.771.982.81.5
Investing Cash Flow
-25.93-32.46-3.26-4.42-6.01-5.82

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-97.37226.81293.77286.337.25
Long-Term Debt Issued
-102.58154.63---
Total Debt Issued
56.93199.95381.45293.77286.337.25
Short-Term Debt Repaid
--196.4-317.81-260.57-212.08-
Long-Term Debt Repaid
--18.37-16.01-12.25-11.88-4.58
Lease Payments
-19.79-18.37-16.01-12.25-11.88-4.58
Total Debt Repaid
-366.61-214.78-333.83-272.82-223.96-4.58
Net Debt Issued (Repaid)
-309.68-14.8247.6220.9562.372.67
Issuance of Common Stock
570.21-21.82---
Repurchase of Common Stock
----29.97-24.87-
Common Dividends Paid
---4.7-60-40-46.82
Financing Cash Flow
260.53-14.8264.73-69.02-2.5-44.15

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
321.15113.7-12.97-111.44126.430.29

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
48.03118.51-86.76-44.44129.6344.44
Free Cash Flow Growth
----191.66%14.31%
Free Cash Flow Margin
4.89%13.25%-16.69%-8.45%17.77%7.48%
Free Cash Flow Per Share
0.060.21-0.15-0.080.230.08
Levered Free Cash Flow
15.5667.9-99.4284.4275.76-1
Unlevered Free Cash Flow
37.4289.42-61.51102.8584.184.1
Free Cash Flow After Leases
28.24100.13-102.78-56.69117.7539.87

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
27.3727.3732.2225.2710.146.26
Cash Income Tax Paid
0.10.10.0548.7945.7142.95
Change in Working Capital
-159.61-33.21-123.0446.67-76.86-125.25